News
The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.
Separately, the FDA on Friday informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, that is approved to treat a different type of muscular dystrophy and was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results